Abstract
This research report is about the worldwide biochip tools, technologies and
services market. Biochips are also known as DNA microarrays, bioarrays,
protein arrays, lab-on-a-chip, labchips, liquid arrays or multiplex arrays.
These key mainstream life science research products and services involve
technologies that scientists use to detect and analyze genetic, protein, or
related material such as DNA, RNA, proteins, antibodies, stem cells, tissues,
biomarkers and so on. This study takes into account the impact of key economic
factors influencing this industry including changing world events,
pharmaceutical industry structural changes, government grant programs for life
science research, changing healthcare laws and more.
This report discusses new biochip products reaching the market including DNA
and RNA products such as high-density arrays, tiling, copy number variation,
SNPs, alternate splice variant arrays, ChIP-Chip, CpG island, DNA methylation,
microRNA, sequence-capture arrays for targeted resequencing, GWAS, array-based
molecular diagnostics and related areas. The study reviews microfluidic
biochips (labchips) such as for POC diagnostics through credit card-sized
devices, for liquid chromatography, or for drug discovery optimization. This
study also discusses commercial developments in protein biochips and SPR
biosensors.
The study shows that biochip product and service vendors are navigating a
challenging market. Takeda Pacific' s report discusses the major areas of this
dynamic market landscape. This report shows various views of this growing
multi-billion dollar market. The report estimates that over its five-year
forecast that the biochip product and services market would reach a high
single-digit growth rate (CAGR). The report charts the developments of
numerous companies involved in this rapidly changing and evolving industry.
This broad study provides interesting data and includes more than 64 tables
and figures. The tables include data about technologies, companies, future
product roadmaps, and more. The report presents partnering deals and includes
several years of alliance and M&A data. The report reviews twenty-four
selected companies, with details including contact information, business and
product overviews, alliances and patents or other details. This fully
searchable PDF report helps busy readers save time. This report uses
hyperlinks to help readers jump to Table of Content items or to text-linked
Internet sites.
This must-have report would benefit people with job titles including CEO, VPs,
Director of Business Development, Research Directors, Entrepreneurs, Venture
Capitalists, Investment Planners, Research Scientists, Consultants or Industry
Analysts.
About Takeda Pacific
Consultants at Takeda Pacific developed this report. The company provides
business consulting that focuses on facilitating business development and
market research projects. The business projects may involve European, Japanese
and North American Life Science companies. Since it' s founding in late 1992,
TP has reviewed or analyzed thousands of Life Science and Technology firms for
its clients.
During the past twelve years, Takeda Pacific has produced over 70 industry
reports about emerging pharma, biotech, med-devices and technology companies
and markets. Takeda Pacific also offers follow-up consulting or custom
research consulting to assist in your business development, benchmarking, or
market assessment projects.
Report Statistics
- Publication Date: August 2009
- Authors: Jay K. Myers, Paula Mitchell Myers
- Number of Pages: 177 pages; can be printed
Table of Contents
1. Market Overview
- The Dynamic and Evolving Biochip Industry
- WW Biochip Market Size and Forecasts: Total and Key Segments
- Biochip Market Trends
- Biochip Trends and Directions
- Technology Trends
- Next Generation Technology
- Product Innovations and Developments
- Company Activities in Array-based Diagnostics
2. Genetic Biochip Products & Services
- Genetic Biochip Products by Segments
- Strategic Alliances and M&As by Segments
- Products by Segments
- Biochip Supply Chain
- Patents by Product Segments
- Vendor Growth and Analysis by Product Segments
- Worldwide Genetic Biochip Market Size and Forecast to 2013
- Methodology
- Revenue Review
- Market Shares of Major Commercial Vendors by Segments
- The Current Status and Future Outlook by Segments
- Price Trends
- Sales and Distribution Roadmap
- Healthcare Issues
- Next Generation Biochip Technology Roadmap
- Genetic Biochip Service Provider Roadmap
- Current & Future Service Providers
- WW Biochip Service Provider Market Size & Forecast to 2013
- Market Share of the Independent Service Providers
- Current and Future: Service Provider' s Roadmap
3. Protein Biochips and Instruments
- Current Status by Product Segments
- Strategic Alliances by Product Segments
- Current & Future Products by Segments
- Protein Biochip Supply Chain
- Patents by the Product Segment
- Company Growth of Protein Biochip Vendors by Segment
- WW Protein Biochip Market Size and Forecast to 2013
- Market Shares of Leading Protein Biochip Vendors
- The Current Status and Future Outlook by Product Segments
- Price Trends
- Sales and Distribution Roadmap
- Healthcare Issues
- Next Generation Technology Roadmap
4. Microfluidic Biochips and Instruments
- Leading Vendor Status by Revenues
- Strategic Alliances and M&As by Date
- Current & Future Microfluidic Biochip Products by Segments
- Microfluidic Biochip Vendor Supply Chain
- Patents of Microfluidic Biochip Vendors by Segment
- Growth & Analysis of Microfluidic Biochip Vendors by Segment
- Worldwide Market Size and Forecast to 2013
- Market Shares of Major Microfluidic Biochip Vendors by Segment
- Current Status and Future Outlook by Product Segments
- Product Price Trends
- Sales and Distribution Roadmap
- Healthcare Issues
- Next Generation Technology Roadmap
5. Activities of Selected Biochip Companies
- Affymetrix, Inc.
- Agilent Technologies, Inc., BAM
- Applied Microarrays, Inc.
- ArrayIt Corporation
- Biolog, Inc.
- BioMicro Systems, Inc.
- Bio-Rad Laboratories, Inc.
- Caliper Life Sciences, Inc.
- CapitalBio Corporation
- CombiMatrix Corporation
- Eppendorf AG
- Expression Analysis, Inc.
- Fluidigm Corporation
- GenTel BioSciences, Inc.
- GWC Technologies, Inc.
- Illumina, Inc.
- Life Technologies, Inc.
- Ocimum Biosolutions, Inc.
- Oxford Gene Technology Ltd.
- SABiosciences Corporation
- SciGene Corporation
- Sequenom, Inc.
- Sigma-Aldrich Corporation
- Tecan Group AG
6. Findings and High Growth Areas
- Major Findings
- Impact of Major Economic Factors and Political Change
- High-Density Whole Genome Biochips
- Market Expansion and Transitions to New Areas
- Biochip-Based Diagnostics
- FDA' s MAQC and Commercial Biochips
- Biochip Demand Shifting to Asia
- Biochip Standardization Efforts
- High-Throughput and Low to Mid- Multiplex Biochip Analysis
- Automated Microfluidic Biochip Systems
- Protein Biochips
- Drug Safety, Genetic Variation and Biochips
- Top Growth Opportunities for Biochip Products
- New Business Opportunities for Companies
- Molecular Diagnostics
- Consider Government/ Academic Customer Markets
- Consider Agricultural/Bio Markets
- Consider Other WW Regions for Cost Savings or New Customers
- Target Marketing Efforts into Asia to Expand Business Opportunities
- Opportunities in Asia
- A Leading Customer and Resource Region
- The Ocimum Model to Grow Globally
7. Appendix
- Company Contact Information by Categories
- About Takeda Pacific
- About the Authors
